Critical role of the calpain/calpastatin balance in acute allograft rejection

Standard

Critical role of the calpain/calpastatin balance in acute allograft rejection. / Letavernier, Emmanuel; Dansou, Boris; Lochner, Matthias; Perez, Joëlle; Bellocq, Agnès; Lindenmeyer, Maja T; Cohen, Clemens D; Haymann, Jean-Philippe; Eberl, Gérard; Baud, Laurent.

in: EUR J IMMUNOL, Jahrgang 41, Nr. 2, 02.2011, S. 473-84.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Letavernier, E, Dansou, B, Lochner, M, Perez, J, Bellocq, A, Lindenmeyer, MT, Cohen, CD, Haymann, J-P, Eberl, G & Baud, L 2011, 'Critical role of the calpain/calpastatin balance in acute allograft rejection', EUR J IMMUNOL, Jg. 41, Nr. 2, S. 473-84. https://doi.org/10.1002/eji.201040437

APA

Letavernier, E., Dansou, B., Lochner, M., Perez, J., Bellocq, A., Lindenmeyer, M. T., Cohen, C. D., Haymann, J-P., Eberl, G., & Baud, L. (2011). Critical role of the calpain/calpastatin balance in acute allograft rejection. EUR J IMMUNOL, 41(2), 473-84. https://doi.org/10.1002/eji.201040437

Vancouver

Bibtex

@article{43d9134a101e4903a194985e266e84c0,
title = "Critical role of the calpain/calpastatin balance in acute allograft rejection",
abstract = "Rejection of solid organ allograft involves alloreactive T-cell expansion. The importance of NF-κB and NFAT in this process is underscored by the therapeutic efficacy of immunosuppressive agents, which target the two transcription factors. Since calpains, calcium-activated proteases, are involved in the activation of NF-κB and NFAT, we investigated the role of calpains in allograft rejection. In human transplant kidneys undergoing acute or chronic rejection, we show an increased expression of CAPN 1 gene encoding μ-calpain, associated with a marked expression of μ-calpain, mainly in infiltrating T cells. To address the role of calpain in rejection, we used a skin transplant model in transgenic mice expressing high levels of calpastatin, a calpain-specific inhibitor. We show that calpain inhibition extended skin allograft survival, from 11 to 20 days. This delay was associated with a limitation in allograft infiltration by T cells. In vitro, calpain inhibition by calpastatin transgene expression limited dramatically T-cell migration but, unexpectedly, increased slightly T-cell proliferation. Amplification of IL-2 signaling via the stabilization of IL-2R common γ-chain provided an explanation for the proliferation response. This is the first study establishing that calpain inhibition delays allograft rejection by slowing down T-cell migration rather than proliferation.",
keywords = "Acrylates, Adoptive Transfer, Animals, Calcium-Binding Proteins, Calpain, Cell Differentiation, Cell Movement, Cell Proliferation, Gene Expression, Graft Rejection, Homeodomain Proteins, Humans, Interleukin-2, Kidney, Kidney Transplantation, Lymphocyte Activation, Lymphocyte Culture Test, Mixed, Male, Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Knockout, Mice, Transgenic, NF-kappa B, NFATC Transcription Factors, Skin Transplantation, T-Lymphocytes, T-Lymphocytes, Cytotoxic, Th17 Cells, Transplantation, Homologous, Journal Article, Research Support, Non-U.S. Gov't",
author = "Emmanuel Letavernier and Boris Dansou and Matthias Lochner and Jo{\"e}lle Perez and Agn{\`e}s Bellocq and Lindenmeyer, {Maja T} and Cohen, {Clemens D} and Jean-Philippe Haymann and G{\'e}rard Eberl and Laurent Baud",
note = "Copyright {\textcopyright} 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.",
year = "2011",
month = feb,
doi = "10.1002/eji.201040437",
language = "English",
volume = "41",
pages = "473--84",
journal = "EUR J IMMUNOL",
issn = "0014-2980",
publisher = "Wiley-VCH Verlag GmbH",
number = "2",

}

RIS

TY - JOUR

T1 - Critical role of the calpain/calpastatin balance in acute allograft rejection

AU - Letavernier, Emmanuel

AU - Dansou, Boris

AU - Lochner, Matthias

AU - Perez, Joëlle

AU - Bellocq, Agnès

AU - Lindenmeyer, Maja T

AU - Cohen, Clemens D

AU - Haymann, Jean-Philippe

AU - Eberl, Gérard

AU - Baud, Laurent

N1 - Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

PY - 2011/2

Y1 - 2011/2

N2 - Rejection of solid organ allograft involves alloreactive T-cell expansion. The importance of NF-κB and NFAT in this process is underscored by the therapeutic efficacy of immunosuppressive agents, which target the two transcription factors. Since calpains, calcium-activated proteases, are involved in the activation of NF-κB and NFAT, we investigated the role of calpains in allograft rejection. In human transplant kidneys undergoing acute or chronic rejection, we show an increased expression of CAPN 1 gene encoding μ-calpain, associated with a marked expression of μ-calpain, mainly in infiltrating T cells. To address the role of calpain in rejection, we used a skin transplant model in transgenic mice expressing high levels of calpastatin, a calpain-specific inhibitor. We show that calpain inhibition extended skin allograft survival, from 11 to 20 days. This delay was associated with a limitation in allograft infiltration by T cells. In vitro, calpain inhibition by calpastatin transgene expression limited dramatically T-cell migration but, unexpectedly, increased slightly T-cell proliferation. Amplification of IL-2 signaling via the stabilization of IL-2R common γ-chain provided an explanation for the proliferation response. This is the first study establishing that calpain inhibition delays allograft rejection by slowing down T-cell migration rather than proliferation.

AB - Rejection of solid organ allograft involves alloreactive T-cell expansion. The importance of NF-κB and NFAT in this process is underscored by the therapeutic efficacy of immunosuppressive agents, which target the two transcription factors. Since calpains, calcium-activated proteases, are involved in the activation of NF-κB and NFAT, we investigated the role of calpains in allograft rejection. In human transplant kidneys undergoing acute or chronic rejection, we show an increased expression of CAPN 1 gene encoding μ-calpain, associated with a marked expression of μ-calpain, mainly in infiltrating T cells. To address the role of calpain in rejection, we used a skin transplant model in transgenic mice expressing high levels of calpastatin, a calpain-specific inhibitor. We show that calpain inhibition extended skin allograft survival, from 11 to 20 days. This delay was associated with a limitation in allograft infiltration by T cells. In vitro, calpain inhibition by calpastatin transgene expression limited dramatically T-cell migration but, unexpectedly, increased slightly T-cell proliferation. Amplification of IL-2 signaling via the stabilization of IL-2R common γ-chain provided an explanation for the proliferation response. This is the first study establishing that calpain inhibition delays allograft rejection by slowing down T-cell migration rather than proliferation.

KW - Acrylates

KW - Adoptive Transfer

KW - Animals

KW - Calcium-Binding Proteins

KW - Calpain

KW - Cell Differentiation

KW - Cell Movement

KW - Cell Proliferation

KW - Gene Expression

KW - Graft Rejection

KW - Homeodomain Proteins

KW - Humans

KW - Interleukin-2

KW - Kidney

KW - Kidney Transplantation

KW - Lymphocyte Activation

KW - Lymphocyte Culture Test, Mixed

KW - Male

KW - Mice

KW - Mice, Inbred BALB C

KW - Mice, Inbred C57BL

KW - Mice, Knockout

KW - Mice, Transgenic

KW - NF-kappa B

KW - NFATC Transcription Factors

KW - Skin Transplantation

KW - T-Lymphocytes

KW - T-Lymphocytes, Cytotoxic

KW - Th17 Cells

KW - Transplantation, Homologous

KW - Journal Article

KW - Research Support, Non-U.S. Gov't

U2 - 10.1002/eji.201040437

DO - 10.1002/eji.201040437

M3 - SCORING: Journal article

C2 - 21268016

VL - 41

SP - 473

EP - 484

JO - EUR J IMMUNOL

JF - EUR J IMMUNOL

SN - 0014-2980

IS - 2

ER -